Volume 26, Issue 2 e14162
BRIEF COMMUNICATION

Decreased access to pediatric liver transplantation during the COVID-19 pandemic

Sarah Kemme

Sarah Kemme

Section of Gastroenterology, Hepatology, and Nutrition, Digestive Health Institute, University of Colorado Denver School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA

Search for more papers by this author
Dor Yoeli

Dor Yoeli

Division of Transplant Surgery, Colorado Center for Transplantation Care, Research and Education, University of Colorado Denver School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA

Search for more papers by this author
Shikha S. Sundaram

Shikha S. Sundaram

Section of Gastroenterology, Hepatology, and Nutrition, Digestive Health Institute, University of Colorado Denver School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA

Search for more papers by this author
Megan A. Adams

Megan A. Adams

Division of Transplant Surgery, Colorado Center for Transplantation Care, Research and Education, University of Colorado Denver School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA

Search for more papers by this author
Amy G. Feldman

Corresponding Author

Amy G. Feldman

Section of Gastroenterology, Hepatology, and Nutrition, Digestive Health Institute, University of Colorado Denver School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA

Correspondence

Amy G. Feldman, 13123 E 16th Ave, Aurora, CO 80045, USA.

Email: [email protected]

Search for more papers by this author
First published: 11 October 2021
Citations: 6

Abstract

Background

The COVID-19 pandemic has affected all aspects of the US healthcare system, including liver transplantation. The objective of this study was to understand national changes to pediatric liver transplantation during COVID-19.

Methods

Using SRTR data, we compared waitlist additions, removals, and liver transplantations for pre-COVID-19 (March-November 2016–2019), early COVID-19 (March-May 2020), and late COVID-19 (June-November 2020).

Results

Waitlist additions decreased by 25% during early COVID-19 (41.3/month vs. 55.4/month, < .001) with black candidates most affected (= .04). Children spent longer on the waitlist during early COVID-19 compared to pre-COVID-19 (140 vs. 96 days, < .001). There was a 38% decrease in liver transplantations during early COVID-19 (IRR 0.62, 95% CI 0.49–0.78), recovering to pre-pandemic rates during late COVID-19 (IRR 1.03, NS), and no change in percentage of living and deceased donors. White children had a 30% decrease in overall liver transplantation but no change in living donor liver transplantation (IRR 0.7, 95% CI 0.50–0.95; IRR 0.96, NS), while non-white children had a 44% decrease in overall liver transplantation (IRR 0.56, 95% CI 0.40–0.77) and 81% decrease in living donor liver transplantation (IRR 0.19, 95% CI 0.02–0.76).

Conclusions

The COVID-19 pandemic decreased access to pediatric liver transplantation, particularly in its early stage. There were no regional differences in liver transplantation during COVID-19 despite the increased national sharing of organs. While pediatric liver transplantation has resumed pre-pandemic levels, ongoing racial disparities must be addressed.

CONFLICT OF INTEREST

The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation.

DATA AVAILABILITY STATEMENT

The raw data that support the findings of this study are available in the SRTR/OPTN database at http://www.srtr.org/. Derived data supporting the findings of this study are available from the corresponding author [AF] on request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.